2019
DOI: 10.1093/ve/vez041
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage

Abstract: Recombination is an important driver of genetic diversity, though it is relatively uncommon in hepatitis C virus (HCV). Recent investigation of sequence data acquired from HCV clinical trials produced twenty-one full-genome recombinant viruses belonging to three putative inter-subtype forms 2b/1a, 2b/1b, and 2k/1b. The 2k/1b chimera is the only known HCV circulating recombinant form (CRF), provoking interest in its genetic structure and origin. Discovered in Russia in 1999, 2k/1b cases have since been detected… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 84 publications
0
4
0
Order By: Relevance
“…However, the spatial component of prevalence can be also crucial in shaping virus diversity. Hepacivirus spatial structure has so far been investigated only at an intraspecies level, for instance, within HCV genotypes (Markov et al 2009;Iles et al 2014;Hostager et al 2019).…”
Section: Discussionmentioning
confidence: 99%
“…However, the spatial component of prevalence can be also crucial in shaping virus diversity. Hepacivirus spatial structure has so far been investigated only at an intraspecies level, for instance, within HCV genotypes (Markov et al 2009;Iles et al 2014;Hostager et al 2019).…”
Section: Discussionmentioning
confidence: 99%
“…HCV recombination events are rare in vivo and recombinant HCV strains are often non-viable in vitro ( Giannini et al, 1999 ;Viazov et al, 20 0 0 ). The circulating recombinant form 2k/1b was first identified in Saint Petersburg ( Kalinina et al, 2002 ;Susser et al, 2017 ), and phylogeographic analysis has suggested that the 2k/1b CRF originated in Russia, with more recent introductions seen in countries outside of this region ( Hostager et al, 2019 ) such as Armenia, Azerbaijan, Georgia, Germany, and Ukraine. Patients infected with HCV 2k/1b have been treated successfully with pan-genotypic DAAs such as glecaprevir/pibrentasvir ( Zubkin et al, 2019 ) and SOF-based regimens ( Hedskog et al, 2015 ;Susser et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…In this study, we report much higher prevalence of HCV infection with the 1a (25%) subtype, and comparable levels of infection with 1b (40%) and 3a (35%) within IDPWID in Odessa. The HCV subtype 1b dominates epidemics in the neighboring Russian Federation (1a – 2.1%; 1b – 52.8%; 3 – 36.3%) and several post-Soviet countries, such as Uzbekistan and Azerbaijan, whilst 1a is more commonly found in western Europe [9, 29]. Higher 1a prevalence amongst HIV co-infected patients compared to the general population has been linked to IDU mediated transmission elsewhere [30], and thus is expected in our study population.…”
Section: Discussionmentioning
confidence: 99%